Drug Description in Trials / DrugBank / KEGG DRUG

  

Search results

No. 薬物名（臨床試験情報から抽出） DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY 指定難病告示番号
1Baseline WLL----1件: 229 💬
2Blood collection----2件: 229, 271 💬
3Brain MRI----3件: 8, 25, 229 💬
4Bronchoalveolar lavage fluid collection----1件: 229 💬
5Centricyte 1000----2件: 85, 229 💬
6GM-CSF----3件: 51, 60, 229 💬
7IV deployment OF csvf IN sterile normal saline IV solution----2件: 85, 229 💬
8Leukine1件: Sargramostim1件: Sargramostim 💬 1件: CSF2RA 💬 4件: Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, Pathways in cancer 💬2件: 28, 229 💬
9Methionine/homocysteine dosage1件: Methionine1件: Methionine 💬 --1件: 229 💬
10Molgramostim1件: Molgramostim1件: Molgramostim 💬 1件: CSF2RA 💬 4件: Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, Pathways in cancer 💬2件: 229, 299 💬
11Molgramostim 300 MCG nebuliser solution1件: Molgramostim1件: Molgramostim 💬 1件: CSF2RA 💬 4件: Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, Pathways in cancer 💬1件: 229 💬
12Molgramostim 300 µG nebulizer solution1件: Molgramostim1件: Molgramostim 💬 1件: CSF2RA 💬 4件: Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, Pathways in cancer 💬1件: 229 💬
13Molgramostim nebuliser solution 300 MCG1件: Molgramostim1件: Molgramostim 💬 1件: CSF2RA 💬 4件: Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, Pathways in cancer 💬1件: 229 💬
14Molgramostim nebulizer solution1件: Molgramostim1件: Molgramostim 💬 1件: CSF2RA 💬 4件: Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, Pathways in cancer 💬2件: 229, 299 💬
15Pari eflow nebulizer system----2件: 229, 299 💬
16Pioglitazone1件: Pioglitazone2件: Pioglitazone hydrochloride ,
Pioglitazone 💬 		1件: NR1C3 💬 12件: AMPK signaling pathway, Efferocytosis, Huntington disease, Lipid and atherosclerosis, Longevity regulating pathway, Non-alcoholic fatty liver disease, Osteoclast differentiation, PPAR signaling pathway, Pathways in cancer, Thermogenesis, Thyroid cancer, Transcriptional misregulation in cancer 💬16件: 2, 6, 13, 15, 20, 46, 49, 65, 67, 81, 86, 220, 229, 265, 298, 299 💬
17Rescue WLL----1件: 229 💬
18RHGM-CSF1件: Regramostim1件: Regramostim 💬 1件: CSF2RA 💬 4件: Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, Pathways in cancer 💬1件: 229 💬
19Rituximab1件: Rituximab1件: Rituximab 💬 1件: MS4A1 💬 1件: Hematopoietic cell lineage 💬52件: 11, 13, 14, 19, 26, 34, 35, 36, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 52, 53, 55, 56, 60, 61, 62, 63, 64, 65, 66, 83, 84, 85, 86, 93, 94, 96, 97, 162, 172, 220, 222, 229, 256, 271, 274, 283, 284, 285, 288, 296, 300, 331 💬
20Sargramostim1件: Sargramostim1件: Sargramostim 💬 1件: CSF2RA 💬 4件: Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, Pathways in cancer 💬7件: 6, 28, 60, 62, 96, 229, 285 💬
21Sterile normal saline FOR intravenous USE----2件: 85, 229 💬
22Thoracic CT scan----1件: 229 💬
23Vitamin B12, B9, B6, C supplementation1件: Cyanocobalamin5件: Cyanocobalamin ,
Vitamin B12 ,
Cyanocobalamin Co 57 ,
Cyanocobalamin Co 58 ,
Cyanocobalamin Co 60 💬 		--1件: 229 💬